CardioToxicity of Implantation and defibrillation testing in TransvenoUs and Subcutaneous implantable defibrillators.

CardioToxicity of Implantation and defibrillation testing in TransvenoUs and Subcutaneous implantable defibrillators. - TITUS Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON47092

Enrollment

Registered

2015-12-22

Start date

2016-07-15

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ICD implantation and defibrillation

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with an ICD indication, according to the European society of cardiology guidelines, who will undergo ICD implantation.

Exclusion criteria

Exclusion criteria: - (Potential) pregnancy

Design outcomes

Primary

Measure	Time frame
Delta troponin level pre versus post ICD implantation	—

Countries

Netherlands

Outcome results